379611000001107: ReQuip 2mg tablets (GlaxoSmithKline) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\ReQuip 2mg tablets (GlaxoSmithKline)
• \UK product\Virtual medicinal product\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \UK product\Virtual therapeutic moiety\Ropinirole\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \UK product\Virtual therapeutic moiety\Ropinirole\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \UK product\Trade family\ReQuip\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing ropinirole\Ropinirole\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing ropinirole\Ropinirole\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing ropinirole\Product containing ropinirole in oral dose form (medicinal product form)\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing ropinirole\Ropinirole\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing ropinirole\Ropinirole\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing ropinirole\Product containing ropinirole in oral dose form (medicinal product form)\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing ropinirole\Ropinirole\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing ropinirole\Ropinirole\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing ropinirole\Product containing ropinirole in oral dose form (medicinal product form)\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Product manufactured as oral dose form\Product containing ropinirole in oral dose form (medicinal product form)\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Product containing autonomic agent\Product containing ropinirole\Ropinirole\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Product containing autonomic agent\Product containing ropinirole\Ropinirole\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Product containing autonomic agent\Product containing ropinirole\Product containing ropinirole in oral dose form (medicinal product form)\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet\ReQuip 2mg tablets (GlaxoSmithKline)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
16962101000001113	ReQuip 2mg tablets (GlaxoSmithKline) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
58189601000001110	ReQuip 2mg tablets (GlaxoSmithKline UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start